James Investment Research Inc Eli Lilly & CO Transaction History

James Investment Research Inc

$829 Million
Q1 2024

A detailed history of James Investment Research Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, James Investment Research Inc holds 14,895 shares of LLY stock, worth $13.5 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

14,895

Previous 17,592 15.33%

Holding current value

$13.5 Million

Previous $10.3 Million 13.0%

% of portfolio

1.4%

Previous 1.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $1.6 Million - $2.14 Million	-2,697 Reduced 15.33%	14,895 $11.6 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $1.05 Million - $1.24 Million	-2,006 Reduced 10.24%	17,592 $10.3 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $1.55 Million - $2.14 Million	-3,565 Reduced 15.39%	19,598 $10.5 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $107,326 - $143,507	306 Added 1.34%	23,163 $10.9 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $179,854 - $211,230	579 Added 2.6%	22,857 $7.85 Million

Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $105,468 - $122,891	-328 Reduced 1.45%	22,278 $8.15 Million
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $595,035 - $678,105	-2,007 Reduced 8.15%	22,606 $7.31 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $4,738 - $5,563	17 Added 0.07%	24,613 $7.98 Million
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $1.36 Million - $1.69 Million	-5,779 Reduced 19.03%	24,596 $7.04 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $97,360 - $120,824	-433 Reduced 1.41%	30,375 $8.39 Million
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $1.24 Million - $1.53 Million	5,606 Added 22.24%	30,808 $7.12 Million
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $157,078 - $203,179	870 Added 3.58%	25,202 $5.78 Million
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $1.15 Million - $1.49 Million	6,992 Added 40.32%	24,332 $4.55 Million
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $3.6 Million - $4.77 Million	-27,607 Reduced 61.42%	17,340 $2.93 Million
Q3 2020 Oct 23, 2020	SELL	$146.22 - $169.13 $445,093 - $514,831	-3,044 Reduced 6.34%	44,947 $6.65 Million
Q2 2020 Jul 24, 2020	BUY	$136.42 - $164.18 $1.63 Million - $1.96 Million	11,946 Added 33.14%	47,991 $7.88 Million
Q1 2020 Apr 22, 2020	BUY	$119.05 - $147.35 $14,881 - $18,418	125 Added 0.35%	36,045 $5 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $4.28 Million - $4.65 Million	-40,034 Reduced 52.71%	35,920 $4.02 Million
Q2 2019 Jul 24, 2019	BUY	$110.79 - $129.32 $2.27 Million - $2.65 Million	20,455 Added 36.86%	75,954 $8.42 Million
Q1 2019 Apr 26, 2019	BUY	$111.31 - $131.02 $6.15 Million - $7.24 Million	55,259 Added 23024.58%	55,499 $7.2 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $46,706 - $53,604	-617 Reduced 72.0%	240 $20,000
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $17,810 - $21,024	240 Added 38.9%	857 $66,000
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $47,552 - $52,778	617	617 $53,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Eli Lilly & CO Transaction History